title: An MDCK cell culture-derived formalin-inactivated influenza virus whole-virion vaccine from an influenza virus library confers cross-protective immunity by intranasal administration in mice.
abstract: It is currently impossible to predict the next pandemic influenza virus strain. We have thus established a library of influenza viruses of all hemagglutinin and neuraminidase subtypes and their genes. In this article, we examine the applicability of a rapid production model for the preparation of vaccines against emerging pandemic influenza viruses. This procedure utilizes the influenza virus library, cell culture-based vaccine production, and intranasal administration to induce a cross-protective immune response. First, an influenza virus reassortant from the library, A/duck/Hokkaido/Vac-3/2007 (H5N1), was passaged 22 times (P22) in Madin-Darby canine kidney (MDCK) cells. The P22 virus had a titer of >2 ×10(8) PFU/ml, which was 40 times that of the original strain, with 4 point mutations, which altered amino acids in the deduced protein sequences encoded by the PB2 and PA genes. We then produced a formalin-inactivated whole-virion vaccine from the MDCK cell-cultured A/duck/Hokkaido/Vac-3/2007 (H5N1) P22 virus. Intranasal immunization of mice with this vaccine protected them against challenges with lethal influenza viruses of homologous and heterologous subtypes. We further demonstrated that intranasal immunization with the vaccine induced cross-reactive neutralizing antibody responses against the homotypic H5N1 influenza virus and its antigenic variants and cross-reactive cell-mediated immune responses to the homologous virus, its variants within a subtype, and even an influenza virus of a different subtype. These results indicate that a rapid model for emergency vaccine production may be effective for producing the next generation of pandemic influenza virus vaccines.
authors: Laboratory of Virology and Vaccinology, Division of Biomedical Research, National Institute of Biomedical Innovation, Osaka, Japan.
authors: Ahmad M
authors: AM
authors: Haredy
authors: Nobuyuki
authors: N
authors: Takenaka
authors: Hiroshi
authors: H
authors: Yamada
authors: Yoshihiro
authors: Y
authors: Sakoda
authors: Masatoshi
authors: M
authors: Okamatsu
authors: Naoki
authors: N
authors: Yamamoto
authors: Takeshi
authors: T
authors: Omasa
authors: Hisao
authors: H
authors: Ohtake
authors: Yasuko
authors: Y
authors: Mori
authors: Hiroshi
authors: H
authors: Kida
authors: Koichi
authors: K
authors: Yamanishi
authors: Shigefumi
authors: S
authors: Okamoto
mesh_terms: D000281:Administration, Intranasal; D000818:Animals; D057134:Antibodies, Neutralizing / Q000097:blood; D000914:Antibodies, Viral / Q000097:blood; D056738:Cross Protection; D004285:Dogs; D005260:Female; D005557:Formaldehyde / Q000378:metabolism; D053124:Influenza A Virus, H5N1 Subtype / Q000235:genetics / Q000276:immunology; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D007963:Leukocytes, Mononuclear / Q000276:immunology; D061985:Madin Darby Canine Kidney Cells; D051379:Mice; D008807:Mice, Inbred BALB C; D016865:Reassortant Viruses / Q000235:genetics / Q000276:immunology; D015164:Vaccines, Inactivated / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology; D038301:Virus Inactivation
chemical_list: D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D007252:Influenza Vaccines; D015164:Vaccines, Inactivated; D005557:Formaldehyde
references: J Gen Virol. 1992 May;73 ( Pt 5):1159-65
references: 1588320
references: PLoS One. 2011 Jan 24;6(1):e14578
references: 21283675
references: J Pediatr. 1998 Nov;133(5):624-8
references: 9821418
references: Vaccine. 2008 Jan 24;26(4):562-72
references: 18164788
references: Vaccine. 2003 May 1;21(16):1776-9
references: 12686093
references: Arch Virol. 2008;153(11):2041-8
references: 18932020
references: Antiviral Res. 2012 Dec;96(3):344-52
references: 23022352
references: Jpn J Vet Res. 2008 Jan;55(2-3):93-8
references: 18318111
references: Arch Virol. 2008;153(9):1685-92
references: 18651092
references: Dev Biol (Basel). 2006;124:69-72
references: 16447496
references: Science. 2001 Sep 7;293(5536):1840-2
references: 11546875
references: Vaccine. 2009 Sep 25;27(42):5896-905
references: 19647814
references: PLoS One. 2012;7(2):e30960
references: 22363523
references: Vaccine. 2009 Dec 9;27(52):7402-8
references: 19747993
references: Vaccine. 2003 Jul 4;21(23):3212-8
references: 12804850
references: J Virol. 2010 Sep;84(17):8389-97
references: 20538856
references: Vaccine. 1998 May-Jun;16(9-10):960-8
references: 9682344
references: Jpn J Infect Dis. 2010 Jan;63(1):8-15
references: 20093755
references: Int J Biochem Cell Biol. 2008;40(12):2671-4
references: 18588994
references: Vaccine. 2008 Oct 23;26(45):5736-40
references: 18761387
references: Biologicals. 2010 Sep;38(5):544-51
references: 20537553
references: Immunology. 2008 Jun;124(2):155-65
references: 18205793
references: Cell. 2005 Nov 4;123(3):368-71
references: 16269328
references: J Immunol. 2006 Jan 15;176(2):1122-30
references: 16394001
references: J Gen Virol. 2010 Jun;91(Pt 6):1450-60
references: 20147516
references: Jpn J Vet Res. 2011 Feb;59(1):23-9
references: 21476487
references: Emerg Infect Dis. 2006 Jun;12(6):881-6
references: 16707041
references: J Virol. 2005 Mar;79(5):2910-9
references: 15709010
references: Nat Med. 2006 Oct;12(10):1203-7
references: 16964257
references: J Virol. 2010 May;84(9):4212-21
references: 20164231
references: J Virol. 2011 Oct;85(20):10691-8
references: 21849466
references: Vaccine. 2009 May 14;27(22):2907-13
references: 19366582
references: Vaccine. 1989 Jun;7(3):257-62
references: 2781859
references: Arch Virol. 2001 Dec;146(12):2275-89
references: 11811679
references: Vaccine. 2004 Jun 2;22(17-18):2202-8
references: 15149778
references: Clin Infect Dis. 2010 Feb 15;50(4):560-5
references: 20085485
references: J Virol. 2005 Sep;79(18):11788-800
references: 16140756
references: J Virol. 2012 Feb;86(3):1405-10
references: 22090129
references: PLoS One. 2012;7(1):e30898
references: 22303469
references: Clin Vaccine Immunol. 2012 Jul;19(7):979-90
references: 22552600
references: Vaccine. 2010 May 14;28(22):3848-55
references: 20307595
references: Vaccine. 2007 Nov 28;25(49):8270-8
references: 17977633
references: Nat Immunol. 2006 May;7(5):449-55
references: 16622432
references: Bull World Health Organ. 1995;73(4):431-5
references: 7554013
references: Clin Infect Dis. 2010 Nov 1;51(9):1005-6
references: 20868285
references: J Virol. 2008 Nov;82(21):10502-9
references: 18768983